BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25387119)

  • 21. LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors.
    Ludwig FA; Smits R; Fischer S; Donat CK; Hoepping A; Brust P; Steinbach J
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27617996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain.
    Horti AG; Villemagne VL
    Curr Pharm Des; 2006; 12(30):3877-900. PubMed ID: 17073685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of both enantiomers of [(18)F]flubatine, promising radiotracers with fast kinetics for the imaging of α4β2-nicotinic acetylcholine receptors.
    Smits R; Fischer S; Hiller A; Deuther-Conrad W; Wenzel B; Patt M; Cumming P; Steinbach J; Sabri O; Brust P; Hoepping A
    Bioorg Med Chem; 2014 Jan; 22(2):804-12. PubMed ID: 24369841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.
    Kadir A; Almkvist O; Wall A; Långström B; Nordberg A
    Psychopharmacology (Berl); 2006 Nov; 188(4):509-20. PubMed ID: 16832659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's Disease.
    Matsuura Y; Ueda M; Higaki Y; Sano K; Saji H; Enomoto S
    Mol Imaging Biol; 2019 Jun; 21(3):519-528. PubMed ID: 30047036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders.
    Tiepolt S; Meyer PM; Patt M; Deuther-Conrad W; Hesse S; Barthel H; Sabri O
    J Nucl Med; 2022 Jun; 63(Suppl 1):33S-44S. PubMed ID: 35649648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine--a promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors.
    Fischer S; Hiller A; Smits R; Hoepping A; Funke U; Wenzel B; Cumming P; Sabri O; Steinbach J; Brust P
    Appl Radiat Isot; 2013 Apr; 74():128-36. PubMed ID: 23416407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Alzheimer's disease imaging agents for clinical studies.
    Ryu EK; Chen X
    Front Biosci; 2008 Jan; 13():777-89. PubMed ID: 17981587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics.
    Kuwabara H; Wong DF; Gao Y; Valentine H; Holt DP; Ravert HT; Dannals RF; Horti AG
    J Nucl Med; 2012 Jan; 53(1):121-9. PubMed ID: 22173841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in Phase-Related Prefrontal Activation During Cognitive Tasks and Nicotinic α4β2 Receptor Availability in Alzheimer's Disease.
    Oboshi Y; Kikuchi M; Terada T; Yoshikawa E; Bunai T; Ouchi Y
    J Alzheimers Dis; 2016 May; 53(3):817-30. PubMed ID: 27258412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys.
    Gallezot JD; Esterlis I; Bois F; Zheng MQ; Lin SF; Kloczynski T; Krystal JH; Huang Y; Sabri O; Carson RE; Cosgrove KP
    Synapse; 2014 Nov; 68(11):556-64. PubMed ID: 25043426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET.
    Ellis JR; Nathan PJ; Villemagne VL; Mulligan RS; Saunder T; Young K; Smith CL; Welch J; Woodward M; Wesnes KA; Savage G; Rowe CC
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):79-91. PubMed ID: 18949462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central in vivo nicotinic acetylcholine receptor imaging agents for positron emission tomography (PET) and single photon emission computed tomography (SPECT).
    Ogawa M; Tsukada H; Hatano K; Ouchi Y; Saji H; Magata Y
    Biol Pharm Bull; 2009 Mar; 32(3):337-40. PubMed ID: 19252274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET imaging in neurology: Alzheimer's and Parkinson's diseases.
    Sarikaya I
    Nucl Med Commun; 2015 Aug; 36(8):775-81. PubMed ID: 25920047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.
    Colloby SJ; O'Brien JT; Fenwick JD; Firbank MJ; Burn DJ; McKeith IG; Williams ED
    Neuroimage; 2004 Nov; 23(3):956-66. PubMed ID: 15528096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A spatial covariance
    Colloby SJ; Field RH; Wyper DJ; O'Brien JT; Taylor JP
    Neurobiol Aging; 2016 Nov; 47():83-90. PubMed ID: 27565302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
    Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo.
    Bucerius J; Joe AY; Schmaljohann J; Gündisch D; Minnerop M; Biersack HJ; Wüllner U; Reinhardt MJ
    Clin Res Cardiol; 2006 Feb; 95(2):105-9. PubMed ID: 16598519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.